Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GANAXOLONE vs GEMFIBROZIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GANAXOLONE vs GEMFIBROZIL: Safety Overview

Metric GANAXOLONE GEMFIBROZIL
Total FAERS Reports 513 1,089
Deaths Reported 13 101
Death Rate 2.5% 9.3%
Hospitalizations 82 286
Average Patient Age 12.7 yrs 56.7 yrs
% Female Patients 72.7% 49.9%
FDA Approval Date Jun 1, 2022 Approved Prior to Jan 1, 1982
Manufacturer Immedica Pharma US Inc Northwind Health Company, LLC
Route ORAL ORAL
Marketing Status Prescription Discontinued